Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1366 AL 1380

Neuroprotective properties of resveratrol and derivatives

Richard T, Pawlus AD, Iglésias ML, Pedrot E, Waffo-Teguo P, Mérillon JM, Monti JP.

Ann N Y Acad Sci. 2011 Jan;1215:103-8. doi: 10.1111/j.1749-6632.2010.05865.x.

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR; NMSS Validation Group.

Mov Disord. 2011 Feb 15;26(3):399-406. doi: 10.1002/mds.23462. Epub 2011 Jan 24.

Mitophagy in neurodegeneration: an opportunity for therapy?

Santos RX, Correia SC, Carvalho C, Cardoso S, Santos MS, Moreira PI.

Curr Drug Targets. 2011 Jun;12(6):790-9. doi: 10.2174/138945011795528813.

An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type

Iwasaki Y, Mori K, Ito M, Nagaoka M, Ieda T, Kitamoto T, Yoshida M, Hashizume Y.

Neuropathology. 2011 Oct;31(5):540-8. doi: 10.1111/j.1440-1789.2010.01192.x. Epub 2011 Jan 27.

From reinforcement learning models to psychiatric and neurological disorders

Maia TV, Frank MJ.

Nat Neurosci. 2011 Feb;14(2):154-62. doi: 10.1038/nn.2723.

Modeling neurodegeneration in zebrafish

Xi Y, Noble S, Ekker M.

Curr Neurol Neurosci Rep. 2011 Jun;11(3):274-82. doi: 10.1007/s11910-011-0182-2.

The impact of attentional, auditory, and combined cues on walking during single and cognitive dual tasks in Parkinson disease

Lohnes CA, Earhart GM.

Gait Posture. 2011 Mar;33(3):478-83. doi: 10.1016/j.gaitpost.2010.12.029. Epub 2011 Jan 26.

Severe parkinsonism following endoscopic third ventriculostomy for non-communicating hydrocephalus--case report

Akiyama T, Tanizaki Y, Akaji K, Hiraga K, Akiyama T, Takao M, Ohira T.

Neurol Med Chir (Tokyo). 2011;51(1):60-3. doi: 10.2176/nmc.51.60.

Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort

Locke MC, Wu SS, Foote KD, Sassi M, Jacobson CE, Rodriguez RL, Fernandez HH, Okun MS.

Neurosurgery. 2011 May;68(5):1233-7; discussion 1237-8. doi: 10.1227/NEU.0b013e31820b52c5.

An atypical cutaneous reaction to rivastigmine transdermal patch

Grieco T, Rossi M, Faina V, De Marco I, Pigatto P, Calvieri S.

J Allergy (Cairo). 2011;2011:752098. doi: 10.1155/2011/752098. Epub 2011 Jan 11.

Neuroimaging in Parkinson's disease

Stoessl AJ.

Neurotherapeutics. 2011 Jan;8(1):72-81. doi: 10.1007/s13311-010-0007-z.

Neuroimaging in dementia

Tartaglia MC, Rosen HJ, Miller BL.

Neurotherapeutics. 2011 Jan;8(1):82-92. doi: 10.1007/s13311-010-0012-2.

N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[(123)I]iodophenyl)nortropane

Leung K.

2004 Dec 16 [updated 2011 Feb 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

N-(3-[(18)F]Fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane

Leung K.

2004 Dec 15 [updated 2011 Feb 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias